Evidence map›Paper›PMID 26040262›Full record

ReviewCurrent hematologic malignancy reports2015

The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology.

Hemant S Murthy, William A Wood

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current hematologic malignancy reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Early experiences with patient generated health data: health system and patient perspectives.Journal of the American Medical Informatics Association : JAMIA · 2019
    Article
  6. Article
  7. Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2019
    Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hemant S MurthyBrody School of Medicine, East Carolina University, 600 Moye Blvd, Greenville, NC, 27834, USA, murthyh@ecu.edu.
William A Wood

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With cures and long-term survival rates increasing in hematologic malignancies, increased focus has been placed on gaining a better understanding of the patient experience from disease and treatment effects. This has been the basis for the utilization of patient reported outcomes (PRO) and other patient-generated health data (PGHD) in efforts to improve long-term health-related quality of life (HRQOL). This review will summarize the impact PROs have had on the evolving standard of care for patients with hematologic malignant conditions and will conclude with a template for the integration of PRO and PGHD to enhance the patient experience, using stem cell transplantation as an example.

Indexed as

Patient Outcome AssessmentSelf ReportDelivery of Health CareDisease ManagementHematologic NeoplasmsHematologyHematopoietic Stem Cell TransplantationHumansNeoplasmsPrognosisQuality of Life

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.